These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38609180)

  • 1. Association of blood eosinophils with corticosteroid treatment failure stratified by smoking status among inpatients with AECOPD.
    Li J; Zuo Y; Feng L; Cai YS; Su J; Tong Z; Liang L
    BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38609180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study.
    Pu J; Yi Q; Luo Y; Wei H; Ge H; Liu H; Li X; Zhang J; Pan P; Zhou H; Zhou C; Yi M; Cheng L; Liu L; Zhang J; Peng L; Aili A; Liu Y; Zhou H;
    Int J Chron Obstruct Pulmon Dis; 2023; 18():169-179. PubMed ID: 36879668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Blood Eosinophil Level in AECOPD is Influenced by Corticosteroid Treatment During Hospitalization.
    Li J; Liang L; Feng L; Cao S; Cai YS; Li X; Qian Z; Brightling CE; Tong Z
    J Inflamm Res; 2023; 16():3233-3243. PubMed ID: 37555013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol.
    Liang L; Lin Y; Feng L; Shao S; Cao S; Rong H; Chu S; Xie W; Cai S; Wang J; Tong Z
    BMJ Open; 2023 May; 13(5):e066354. PubMed ID: 37247957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance.
    Al Sibani M; Al Alawi A; Al Aghbari J
    Sultan Qaboos Univ Med J; 2022 Aug; 22(3):339-342. PubMed ID: 36072062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Eosinophils and Clinical Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis of Real-World Data in China.
    Cui Y; Zhan Z; Zeng Z; Huang K; Liang C; Mao X; Zhang Y; Ren X; Yang T; Chen Y
    Front Med (Lausanne); 2021; 8():653777. PubMed ID: 34179040
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
    Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
    Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study.
    Suehs CM; Zysman M; Chenivesse C; Burgel PR; Couturaud F; Deslee G; Berger P; Raherison C; Devouassoux G; Brousse C; Roche N; Molimard M; Chinet T; Devillier P; Chanez P; Kessler R; Didier A; Martinat Y; Le Rouzic O; Bourdin A
    BMJ Open; 2020 Jul; 10(7):e035811. PubMed ID: 32611741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability in eosinophil categorisation during subsequent severe exacerbations of COPD.
    Citgez E; van der Palen J; van der Valk P; Kerstjens HAM; Brusse-Keizer M
    BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
    Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS
    BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
    Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD.
    Prins HJ; Duijkers R; Lutter R; Daniels JM; van der Valk P; Schoorl M; Kerstjens HA; van der Werf TS; Boersma WG
    Respir Med; 2017 Oct; 131():118-124. PubMed ID: 28947018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
    Sivapalan P; Lapperre TS; Janner J; Laub RR; Moberg M; Bech CS; Eklöf J; Holm FS; Armbruster K; Sivapalan P; Mosbech C; Ali AKM; Seersholm N; Wilcke JT; Brøndum E; Sonne TP; Rønholt F; Andreassen HF; Ulrik CS; Vestbo J; Jensen JS
    Lancet Respir Med; 2019 Aug; 7(8):699-709. PubMed ID: 31122894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Nomograms Using Routine Biomarkers Beyond Eosinophil Levels: Enhancing Predictability of Corticosteroid Treatment Outcomes in AECOPD.
    Feng L; Li J; Qian Z; Li C; Gao D; Wang Y; Xie W; Cai Y; Tong Z; Liang L
    J Inflamm Res; 2024; 17():1511-1526. PubMed ID: 38476472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
    Cui Y; Zhang W; Ma Y; Zhan Z; Chen Y
    Respir Res; 2021 Nov; 22(1):301. PubMed ID: 34819051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
    Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.
    Choi J; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Kang KH; Min KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():953-959. PubMed ID: 31190782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.